Ajay Madan Net Worth & Insider Trades
Ajay Madan - Chief Development Officer, Crinetics Pharmaceuticals, Inc
What is Ajay Madan's Net Worth?
The current estimated net worth of Crinetics Pharmaceuticals, Inc's Chief Development Officer, Ajay Madan, is estimated to be about $3.87M . Ajay Madan owns about 176,995 units of Crinetics Pharmaceuticals, Inc common stock. In the last year at Crinetics Pharmaceuticals, Inc, Ajay Madan has sold an estimated value of $239.08K worth.
What is Ajay Madan's Past Insider Trading?
Ajay Madan's largest purchase order was 22,950 units , worth over $178.92K on March 2, 2022. Ajay Madan's largest sale order was 13,411 units , worth over $239.08K on February 9, 2022. In total, Ajay Madan has made about 4 transactions over a year of their time at Crinetics Pharmaceuticals, Inc. Ajay Madan usually trades in March, with the busiest year in 2021 and 2022.
Ajay Madan
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What was Ajay Madan's Salary in 2020?
As Chief Development Officer of Crinetics Pharmaceuticals, Inc, Ajay Madan has a total base salary of $412,967 . Ajay Madan received compensation valued at about $1,619,627 in 2020 after becoming Chief Development Officer. The vast majority of their compensation came in the form of option awards of $1,052,100 , other earnings, plans or compensations of $154,560 , and
What is Ajay Madan's' Mailing Address?
- Mailing address is C/o Crinetics Pharmaceuticals, Inc. 10222 Barnes Canyon Road, Bldg. 2 San Diego CA 92121 CA
Crinetics Pharmaceuticals, Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|---|
| R. Scott Struthers | 2020 | $543,550 | - | - | $3,006,000 | $276,782 | - | $3,826,332 |
| R. Scott Struthers | 2019 | $541,708 | - | - | $3,051,275 | $173,679 | - | $3,766,662 |
| Marc. S. Wilson | 2020 | $384,200 | - | - | $1,052,100 | $143,520 | - | $1,579,820 |
| Marc. S. Wilson | 2019 | $364,749 | - | - | $973,811 | $85,248 | - | $1,423,808 |
| Ajay Madan | 2020 | $412,967 | - | - | $1,052,100 | $154,560 | - | $1,619,627 |
| No matching records found | ||||||||
Source: https://www.sec.gov/Archives/edgar/data/1658247/000156459021022087/crnx-def14a_20210622.htm
What are Crinetics Pharmaceuticals, Inc's Past Insider Trades?
Crinetics Pharmaceuticals, Inc's most recent insider trade came on April 5, 2023 by Dana Pizzuti who sold 12,500 units worth $201.15K . In the last 5 years, insiders at Crinetics Pharmaceuticals, Inc have sold an estimated value of $45.31M and bought an estimated value of $63.19M worth of shares. Insider trading is most common in March, with the busiest year in 2022. The most active traders at the company are Stephen Betz, Chief Scientific Officer, Scott Richard Struthers, President & CEO, and Matthew Fust, Director .
Crinetics Pharmaceuticals, Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||